Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling
Open Access
- 27 July 2014
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 5 (17), 7549-7562
- https://doi.org/10.18632/oncotarget.2273
Abstract
Transforming growth factor (TGF)-β-activating kinase 1 (TAK1) is a serine/threonine kinase which is frequently associated with human cancer progression. However, its functional role in tumorigenesis is still controversial. Here, we report that TAK1 enhances the oncogenic capacity of ovarian cancer cells through the activation of NF-κB signaling. We found that TAK1 is frequently upregulated and significantly associated with high-grade and metastatic ovarian cancers. Mechanistic studies showed that Ser412 phosphorylation is required for TAK1 in activating NF-κB signaling and promotes aggressiveness of ovarian cancer cells. Conversely, suppression of TAK1 activity by point mutation at Ser412, RNAi mediated gene knockdown or TAK1 specific inhibitor ((5Z) -7-Oxozeaenol) remarkably impairs tumor growth and metastasis in ovarian cancer in vitro and in vivo. Our study underscores the importance of targeting TAK1 as a promising therapeutic approach to counteract the ovarian cancer progression.Keywords
This publication has 50 references indexed in Scilit:
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon CancersCell, 2012
- The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammationNature Immunology, 2011
- Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1JNCI Journal of the National Cancer Institute, 2011
- A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF-κB and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA DamageMolecular and Cellular Biology, 2011
- Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancerCancer Causes & Control, 2011
- A-kinase-interacting Protein 1 (AKIP1) Acts as a Molecular Determinant of PKA in NF-κB SignalingPublished by Elsevier BV ,2010
- Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancerCancer, 2010
- Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Interaction between TAK1–TAB1–TAB2 and RCAN1–calcineurin defines a signalling nodal control pointNature, 2009
- Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene ExpressionPublished by Elsevier BV ,2008